We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
-0.42%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+409.32%
AUM
$260B
AUM Growth
+$4.9B
Cap. Flow
+$8.05B
Cap. Flow %
3.09%
Top 10 Hldgs %
11.81%
Holding
6,975
New
212
Increased
3,126
Reduced
2,887
Closed
143

Sector Composition

Rank Sector Weight
1 Technology 8.95%
2 Financials 8.74%
3 Healthcare 8.55%
4 Energy 7.45%
5 Communication Services 7.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
USAU icon
6476
US Gold Corp
USAU
$223M
0
USDU icon
6477
WisdomTree Bloomberg US Dollar Bullish Fund
USDU
$455M
-199
Closed -$5K
VIRC icon
6478
Virco
VIRC
$94.4M
$0 ﹤0.01%
25
-500
-95% -$1.3K
VRDN icon
6479
Viridian Therapeutics
VRDN
$2.2B
0
XTLB
6480
XTL Biopharmaceuticals
XTLB
$7M
0
XTIA icon
6481
XTI Aerospace
XTIA
$58.9M
0
AIFC
6482
AI Financial Corp
AIFC
$52.1M
$0 ﹤0.01%
2
-200
-99% -$3.43K
QCLS
6483
Q/C Technologies Inc
QCLS
$21.3M
0
ORKA
6484
Oruka Therapeutics
ORKA
$5.9B
0
IRD
6485
Opus Genetics
IRD
$317M
-2,575
Closed -$1.07M
GRCE
6486
Grace Therapeutics
GRCE
$33.7M
0
RDGT
6487
Ridgetech Inc
RDGT
$2.87M
0
TGEN
6488
Tecogen Inc
TGEN
$95.7M
$0 ﹤0.01%
27
WHLM
6489
DELISTED
Wilhelmina International, Inc
WHLM
$0 ﹤0.01%
+25
New +$156
HMNF
6490
DELISTED
HMN Financial Inc
HMNF
$0 ﹤0.01%
8
+1
+14% +$12
BIMI
6491
DELISTED
BIMI International Medical Inc. Common Stock
BIMI
0
MMAT
6492
DELISTED
Meta Materials Inc. Common Stock
MMAT
0
DYNT
6493
DELISTED
Dynatronics Corp
DYNT
$0 ﹤0.01%
1
NURO
6494
DELISTED
NeuroMetrix, Inc. Common Stock
NURO
0
GENE
6495
DELISTED
Genetic Technologies Ltd.
GENE
0
EIGR
6496
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
-5
Closed -$38K
SCTL
6497
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
-14
Closed
CBAY
6498
DELISTED
Cymabay Therapeutics
CBAY
$0 ﹤0.01%
+25
New +$154
YVR
6499
DELISTED
Liquid Media Group Ltd. Common Shares
YVR
0
MLVF
6500
DELISTED
Malvern Bancorp, Inc.
MLVF
$0 ﹤0.01%
11

Similar funds

Morgan Stanley's Q3 2014 Portfolio in Review

As of Q3 2014, Morgan Stanley held 6,975 positions worth $260B, up 1.9% from $255B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Morgan Stanley deployed $8.05B of net new capital in Q3 2014, opening 212 new positions and adding to 3,126 existing holdings. Its largest new stake was Alibaba: 5,664,434 shares worth $503M.

By sector, the portfolio is most concentrated in Technology at 9% of assets, up from 8.7% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $771M trimmed.

  • Morgan Stanley's largest Q3 2014 buy was Alibaba: 5,664,434 shares worth $503M.
  • Morgan Stanley added most to State Street SPDR S&P 500 ETF Trust in Q3 2014, an estimated $1B increase.
  • Morgan Stanley's biggest Q3 2014 reduction was iShares Russell 2000 ETF, cutting an estimated $771M.
  • Morgan Stanley fully exited TEXAS INDUSTRIES INC in Q3 2014, selling an estimated $384M.
  • Morgan Stanley's ten largest holdings make up 12% of its $260B portfolio in Q3 2014.
  • Morgan Stanley opened 212 new positions and closed 143 in Q3 2014.
  • Morgan Stanley's portfolio value rose 1.9% quarter-over-quarter to $260B.

Based on Morgan Stanley's 13F filing for Q3 2014, filed 14 Nov 2014.